These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 3731218)

  • 21. Tripartite meeting. Paediatric regulatory guidelines: do they help in optimizing dose selection for children?
    Baber NS
    Br J Clin Pharmacol; 2005 Jun; 59(6):660-2. PubMed ID: 15948928
    [No Abstract]   [Full Text] [Related]  

  • 22. Natural products to drugs: natural product-derived compounds in clinical trials.
    Butler MS
    Nat Prod Rep; 2008 Jun; 25(3):475-516. PubMed ID: 18497896
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinical testing of drugs].
    Begemann H
    Med Klin; 1973 May; 68(18):569-71. PubMed ID: 4576603
    [No Abstract]   [Full Text] [Related]  

  • 24. [Clinical testing of drugs].
    Elis J
    Cesk Zdrav; 1973; 21(3):126-30. PubMed ID: 4580127
    [No Abstract]   [Full Text] [Related]  

  • 25. [How to assess the risk of drugs?].
    Roujeau JC
    Ann Dermatol Venereol; 1998 Oct; 125(10):673-5. PubMed ID: 9835953
    [No Abstract]   [Full Text] [Related]  

  • 26. International Conference on Harmonisation; guidance on E14 Clinical Evaluation of QT/QTc Interval Prolongation and Proarrhythmic Potential for Non-Antiarrhythmic Drugs; availability. Notice.
    Food and Drug Administration, HHS
    Fed Regist; 2005 Oct; 70(202):61134-5. PubMed ID: 16237860
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Natural products to drugs: natural product derived compounds in clinical trials.
    Butler MS
    Nat Prod Rep; 2005 Apr; 22(2):162-95. PubMed ID: 15806196
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The drug commission of German physicians and phase IV screening].
    Ochsenfahrt H
    MMW Munch Med Wochenschr; 1983 Oct; 125(42):929-32. PubMed ID: 6417498
    [No Abstract]   [Full Text] [Related]  

  • 29. [Post launch studies].
    Akaza H; Ohashi Y; Shimada Y; Ikeda T; Saijo N; Isonishi S; Hirao Y; Tsuruo T; Tsukagoshi S; Sone S; Nakamura S; Kato M; Mikami O; von Euler M; Blackledge G; Milsted B; Vose B
    Gan To Kagaku Ryoho; 2002 Nov; 29(11):2037-48. PubMed ID: 12465411
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The significance of properly designed pre-clinical studies in the clinical evaluation of new drugs.
    Garrett ER
    Int Z Klin Pharmakol Ther Toxikol; 1970 Dec; 4(1):6-20. PubMed ID: 4924331
    [No Abstract]   [Full Text] [Related]  

  • 31. [Development of anti-cancer drugs under new renewed GCP--from the viewpoint of drug development company developer].
    Ueno T; Kobayashi T; Inoue K; Yanagi Y; Yamada Y
    Gan To Kagaku Ryoho; 1998 Apr; 25(5):663-70. PubMed ID: 9571963
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Drugs from drawing-board to patient.
    Burley DM
    Nurs Times; 1968 Dec; 64(50):1684-6. PubMed ID: 4884014
    [No Abstract]   [Full Text] [Related]  

  • 33. Is it safe to try new drugs when they first come on the market?
    Mayo Clin Womens Healthsource; 2006 Oct; 10(10):10. PubMed ID: 16977278
    [No Abstract]   [Full Text] [Related]  

  • 34. [Clinical trial of drugs (4): trial of drugs against angina pectoris].
    Bjorntorp P
    Lakartidningen; 1970 Jun; 67():Suppl II:73+. PubMed ID: 4921726
    [No Abstract]   [Full Text] [Related]  

  • 35. Clinical investigation of new drugs.
    Pugsley LI
    Appl Ther; 1966 Mar; 8(3):243-9. PubMed ID: 5324973
    [No Abstract]   [Full Text] [Related]  

  • 36. Investigational drugs.
    Am J Hosp Pharm; 1968 Feb; 25(2):91-3. PubMed ID: 4868457
    [No Abstract]   [Full Text] [Related]  

  • 37. Investigational drugs.
    Am J Hosp Pharm; 1967 Dec; 24(12):708-12. PubMed ID: 4864228
    [No Abstract]   [Full Text] [Related]  

  • 38. Drugs and the elderly.
    Abrams WB
    Ration Drug Ther; 1985 Jun; 19(6):1-6. PubMed ID: 3906758
    [No Abstract]   [Full Text] [Related]  

  • 39. Drug therapy 1972. 13. The safety of drugs.
    Smith SE
    Nurs Times; 1972 Aug; 68(34):1067-8. PubMed ID: 4561067
    [No Abstract]   [Full Text] [Related]  

  • 40. [The adverse effects of drugs: the hidden part of the iceberg].
    Roca-Cusachs A; Rodicio JL
    Med Clin (Barc); 1999 Apr; 112(13):516-7. PubMed ID: 10353120
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.